564 related articles for article (PubMed ID: 33652870)
1. Targeting Microglia-Synapse Interactions in Alzheimer's Disease.
Piccioni G; Mango D; Saidi A; Corbo M; Nisticò R
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652870
[TBL] [Abstract][Full Text] [Related]
2. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
3. TREM2 and Microglia Contribute to the Synaptic Plasticity: from Physiology to Pathology.
Yu CJ; Wang M; Li RY; Wei T; Yang HC; Yin YS; Mi YX; Qin Q; Tang Y
Mol Neurobiol; 2023 Feb; 60(2):512-523. PubMed ID: 36318443
[TBL] [Abstract][Full Text] [Related]
4. Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research.
Morris GP; Clark IA; Zinn R; Vissel B
Neurobiol Learn Mem; 2013 Oct; 105():40-53. PubMed ID: 23850597
[TBL] [Abstract][Full Text] [Related]
5. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
Qu W; Li L
Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
[TBL] [Abstract][Full Text] [Related]
6. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
Qu W; Li L
J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
[TBL] [Abstract][Full Text] [Related]
7. Chronic exposure of alcohol triggers microglia-mediated synaptic elimination inducing cognitive impairment.
Lan L; Wang H; Zhang X; Shen Q; Li X; He L; Rong X; Peng J; Mo J; Peng Y
Exp Neurol; 2022 Jul; 353():114061. PubMed ID: 35367455
[TBL] [Abstract][Full Text] [Related]
8. TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology.
Fracassi A; Marcatti M; Tumurbaatar B; Woltjer R; Moreno S; Taglialatela G
Brain Pathol; 2023 Jan; 33(1):e13108. PubMed ID: 35816404
[TBL] [Abstract][Full Text] [Related]
9. Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk.
McQuade A; Blurton-Jones M
J Mol Biol; 2019 Apr; 431(9):1805-1817. PubMed ID: 30738892
[TBL] [Abstract][Full Text] [Related]
10. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
[TBL] [Abstract][Full Text] [Related]
11. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
12. Intersection of pathological tau and microglia at the synapse.
Vogels T; Murgoci AN; Hromádka T
Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
[TBL] [Abstract][Full Text] [Related]
13. CD200 dysfunction in neuron contributes to synaptic deficits and cognitive impairment.
Feng D; Huang A; Yan W; Chen D
Biochem Biophys Res Commun; 2019 Sep; 516(4):1053-1059. PubMed ID: 31277944
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
16. Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.
Spangenberg EE; Green KN
Brain Behav Immun; 2017 Mar; 61():1-11. PubMed ID: 27395435
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and mechanism of cGAMP to suppress Alzheimer's disease by elevating TREM2.
Xu Q; Xu W; Cheng H; Yuan H; Tan X
Brain Behav Immun; 2019 Oct; 81():495-508. PubMed ID: 31283973
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Role of TREM2 in Alzheimer's Disease.
Ulrich JD; Ulland TK; Colonna M; Holtzman DM
Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958
[TBL] [Abstract][Full Text] [Related]
19. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore.
Gussago C; Casati M; Ferri E; Arosio B
J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915
[TBL] [Abstract][Full Text] [Related]
20. CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer's disease.
Zhang L; Xu J; Gao J; Wu Y; Yin M; Zhao W
Rev Neurosci; 2018 Nov; 29(8):837-848. PubMed ID: 29729150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
